UnknownNot Applicable

Megaprosthetic Implants the Next Generation (MING)

30 participantsStarted 2019-02-01

Plain-language summary

This is an interventional randomized controlled trial that will compare patients who underwent segmental hip replacement using mega-implants with either porous collar or porous collar with HA. Patient recruitment will continue for 18 months. Parameters to be investigated are radiographic measures of bone incorporation into the implants, as well as patient functional outcomes. Clinical follow-up will last for 24 months for each patient.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Bone cancer patients requiring primary or revision femoral segmental replacements (excluding infections) and non-cancer patients requiring revision femoral segment replacement for aseptic loosening (excluding infections) * Male or female, aged 18-80 years * Participants willing and able to give informed consent for participation in the study Exclusion Criteria: * Participants unwilling or unable to give informed consent for participation in the study * Patients undergoing revision due to infection, identified by positive growth from joint aspiration OR elevated pre-operative inflammatory markers OR radiographical evidence of prosthetic joint infection * Bone cancer patients presenting with pathological fractures requiring segmental femoral replacement

What they're measuring

Bone incorporation

Timeframe: 24 months

Trial details

NCT IDNCT03780036

SponsorTel-Aviv Sourasky Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-08-01

Contact for this trial

Haggai Schermann, MD, MPH

528771014 sheralmi@bu.edu

View on ClinicalTrials.gov More Bone Neoplasm of Hip (Diagnosis) trials